1997
Acute and Long-Term Outcome After Palmaz-Schatz Stenting: Analysis From the New Approaches To Coronary Intervention (NACI) Registry
Carrozza J, Schatz R, George C, Leon M, King S, Hirshfeld J, Curry R, Ivanhoe R, Buchbinder M, Cleman M, Goldberg S, Ricci D, Popma J, Safian R, Baim D, Investigators F. Acute and Long-Term Outcome After Palmaz-Schatz Stenting: Analysis From the New Approaches To Coronary Intervention (NACI) Registry. The American Journal Of Cardiology 1997, 80: 78k-88k. PMID: 9409695, DOI: 10.1016/s0002-9149(97)00767-4.Peer-Reviewed Original ResearchConceptsPalmaz-Schatz stentsStent Restenosis StudyTarget lesion revascularizationCoronary Intervention RegistryRecent myocardial infarctionMinimum lumen diameterMyocardial infarctionLesion revascularizationIntervention RegistryProcedural successCoronary arteryHigh riskHigh incidenceLumen diameterSignificant left main stenosisLeft main coronary arteryQ-wave myocardial infarctionPalmaz-Schatz stentingDe novo lesionsLeft main stenosisSaphenous vein graftsCohort of patientsCongestive heart failureMain coronary arteryNative coronary arteries
1990
Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol®11Fluosol® (20% Intravascular Perfluorochemical Emulsion) is a registered trademark of The Green Cross Corporation, Osaka, Japan.
Kent K, Cleman M, Cowley M, Forman M, Jaffe C, Kaplan M, King S, Krucoff M, Lassar T, McAuley B, Smith R, Wisdom C, Wohlgelernter D. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol®11Fluosol® (20% Intravascular Perfluorochemical Emulsion) is a registered trademark of The Green Cross Corporation, Osaka, Japan. The American Journal Of Cardiology 1990, 66: 279-284. PMID: 2195864, DOI: 10.1016/0002-9149(90)90836-p.Peer-Reviewed Original ResearchConceptsOxygen-carrying perfluorochemical emulsionFluosol perfusionAngioplasty patientsMyocardial ischemiaPerfluorochemical emulsionBaseline levelsGlobal left ventricular ejection fractionLeft ventricular ejection fractionPercutaneous transluminal coronary angioplastyRegional wall dysfunctionSevere anginal painTransluminal coronary angioplastyVentricular ejection fractionST-segment changesAnginal painGreen Cross CorporationCoronary angioplastyEjection fractionMulticenter trialRoutine angioplastyVentricular functionBalloon occlusionBalloon deflationPatient populationBalloon inflation